These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30721984)

  • 1. Disruption of Cortical Dopaminergic Modulation Impairs Preparatory Activity and Delays Licking Initiation.
    Chen K; Vincis R; Fontanini A
    Cereb Cortex; 2019 Apr; 29(4):1802-1815. PubMed ID: 30721984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
    Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
    Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
    Zhang K; Chammas C; Soghomonian JJ
    Neuroscience; 2015 Sep; 303():586-94. PubMed ID: 26188284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
    Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
    J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
    Özkan M; Johnson NW; Sehirli US; Woodhall GL; Stanford IM
    PLoS One; 2017; 12(7):e0181633. PubMed ID: 28732063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graded 6-OHDA-induced dopamine depletion in the nigrostriatal pathway evokes progressive pathological neuronal activities in the subthalamic nucleus of a hemi-parkinsonian mouse.
    Park SE; Song KI; Kim H; Chung S; Youn I
    Behav Brain Res; 2018 May; 344():42-47. PubMed ID: 29452192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats.
    Wang Q; Wang PH; McLachlan C; Wong PT
    Brain Res; 2005 May; 1045(1-2):229-33. PubMed ID: 15910782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for sucrose.
    D'Aquila PS
    Neuropharmacology; 2010 Jun; 58(7):1085-96. PubMed ID: 20149807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.
    Konieczny J; Czarnecka A; Lenda T; Kamińska K; Antkiewicz-Michaluk L
    Neuroscience; 2017 Jan; 340():308-318. PubMed ID: 27826109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.
    Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S
    Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism.
    Adu TS; Mabandla MV
    Metab Brain Dis; 2019 Dec; 34(6):1557-1564. PubMed ID: 31332728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Type-Specific Decrease of the Intrinsic Excitability of Motor Cortical Pyramidal Neurons in Parkinsonism.
    Chen L; Daniels S; Kim Y; Chu HY
    J Neurosci; 2021 Jun; 41(25):5553-5565. PubMed ID: 34006589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A partial lesion model of Parkinson's disease in mice--characterization of a 6-OHDA-induced medial forebrain bundle lesion.
    Boix J; Padel T; Paul G
    Behav Brain Res; 2015 May; 284():196-206. PubMed ID: 25698603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice.
    Rinaldi A; Mandillo S; Oliverio A; Mele A
    Neuropsychopharmacology; 2007 Feb; 32(2):309-19. PubMed ID: 16900106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity.
    Volta M; Viaro R; Trapella C; Marti M; Morari M
    Exp Neurol; 2011 Mar; 228(1):126-37. PubMed ID: 21215744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible ablation of dopamine D2 receptors in adult mice impairs locomotion, motor skill learning and leads to severe parkinsonism.
    Bello EP; Casas-Cordero R; Galiñanes GL; Casey E; Belluscio MA; Rodríguez V; Noaín D; Murer MG; Rubinstein M
    Mol Psychiatry; 2017 Apr; 22(4):595-604. PubMed ID: 27431292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
    Bagga V; Dunnett SB; Fricker RA
    Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.